A number of experimental studies have shown beneficial effects of angiotensin-converting enzyme (ACE) inhibitors in various models of advanced kidney disease, including 5/6 nephrectomy models with extensive removal of nephron mass. This evidence concerns the gene ACE and kidney disorder.